Do you want to stay up to date on the latest from Cancer Nanotechnology? Sign up for article alerts and news from this journal in order to receive updates for recently published articles, as well as news about Cancer Nanotechnology and BMC.
Basic, translational and clinical research
Cancer is a group of diseases driven by inherently nanostructural problems. As such, there are obvious benefits to treatments employing nanoscale structures and processes. Cancer Nanotechnology aims to provide a forum so that the most promising emerging themes should be pre-eminent in the minds of researchers working in one—or, indeed, both—of the disciplines of cancer research or nanotechnology.
Click the link to read more about the journal.
Special article collections
Cancer Nanotechnology publishes special article collections on specific topics. Be sure to take a look at the list of collections we have so far by clicking the link above.
We welcome further submissions to these collections.
Alternatively, maybe you have a suggestion for a special collection of your own that you would like to edit. We'd love to hear from you if so!
Articles
-
-
Polyethylenimine-CO2 adduct templated CaCO3 nanoparticles as anticancer drug carrier
-
Pristine/folate-functionalized graphene oxide as two intrinsically radioiodinated nano-theranostics: self/dual in vivo targeting comparative study
-
Curcumin-loaded nanocomplexes alleviate the progression of fluke-related cholangiocarcinoma in hamsters
-
Preparation and characterization of cetuximab-loaded egg serum albumin nanoparticles and their uses as a drug delivery system against Caco-2 colon cancer cells
-
Particle therapy and nanomedicine: state of art and research perspectives
-
Nanomedicine review: clinical developments in liposomal applications
-
Biological mechanisms of gold nanoparticle radiosensitization
-
Cisplatin-loaded hollow gold nanoparticles for laser-triggered release
-
Dye-doped silica nanoparticles: synthesis, surface chemistry and bioapplications
Stay up to date
We are recruiting new Associate Editors!
Are you a researcher active in the field of cancer nanotechnology and want to join our editorial team? We have vacancies for new Associate Editors to help us as we grow the journal.
Click here for more information.
Latest Tweets
Your browser needs to have JavaScript enabled to view this timeline
Follow
Journal Metrics
-
Citation Impact
7.917 - 2-year Impact Factor (2021)
6.8 - CiteScore
1.387 - Source Normalized Impact per Paper (SNIP)
0.921 - SCImago Journal Rank (SJR)Speed
47 days to first decision for all manuscripts (Median)
53 days to first decision for reviewed manuscripts only (Median)Usage
123,999 downloads (2021)
91 Altmetric mentions (2021)
- ISSN: 1868-6966 (electronic)
- ISSN: 1868-6958 (print)